
### [MONDO:0016122](http://purl.obolibrary.org/obo/MONDO_0016122)
**Label:** periodic paralysis (disease)

**Subclasses:** [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), 

**Corr. equiv. classes:** [OMIM:613345](http://purl.obolibrary.org/obo/OMIM_613345), [Orphanet:681](http://www.orpha.net/ORDO/Orphanet_681), [OMIM:613239](http://purl.obolibrary.org/obo/OMIM_613239), [OMIM:614834](http://purl.obolibrary.org/obo/OMIM_614834), [OMIM:188580](http://purl.obolibrary.org/obo/OMIM_188580), [Orphanet:79102](http://www.orpha.net/ORDO/Orphanet_79102), [OMIM:170400](http://purl.obolibrary.org/obo/OMIM_170400), 

**Class expressions from DL-Learner:**

- [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 64.29%
- [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) and [HP:0012726](http://purl.obolibrary.org/obo/HP_0012726) (Episodic hypokalemia) 64.29%
- [HP:0011998](http://purl.obolibrary.org/obo/HP_0011998) (Postprandial hyperglycemia) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0011042](http://purl.obolibrary.org/obo/HP_0011042) (Abnormality of potassium homeostasis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0011021](http://purl.obolibrary.org/obo/HP_0011021) (Abnormality of circulating enzyme level) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0011015](http://purl.obolibrary.org/obo/HP_0011015) (Abnormality of blood glucose concentration) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0011014](http://purl.obolibrary.org/obo/HP_0011014) (Abnormal glucose homeostasis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0011013](http://purl.obolibrary.org/obo/HP_0011013) (Abnormality of carbohydrate metabolism/homeostasis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0010930](http://purl.obolibrary.org/obo/HP_0010930) (Abnormality of monovalent inorganic cation homeostasis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0010876](http://purl.obolibrary.org/obo/HP_0010876) (Abnormality of circulating protein level) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0009020](http://purl.obolibrary.org/obo/HP_0009020) (Exercise-induced muscle fatigue) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%
- [HP:0008153](http://purl.obolibrary.org/obo/HP_0008153) (Periodic hypokalemic paresis) and [HP:0012240](http://purl.obolibrary.org/obo/HP_0012240) (Increased intramyocellular lipid droplets) 64.29%


